Progress in Applications of Prussian Blue Nanoparticles in Biomedicine

Adv Healthc Mater. 2018 Oct;7(20):e1800347. doi: 10.1002/adhm.201800347. Epub 2018 Jul 4.

Abstract

Prussian blue nanoparticles (PBNPs) with favorable biocompatibility and unique properties have captured the attention of extensive biomedical researchers. A great progress is made in the application of PBNPs as therapy and diagnostics agents in biomedicine. This review begins with the recent synthetic strategies of PBNPs and the regulatory approaches for their size, shape, and uniformity. Then, according to the different properties of PBNPs, their application in biomedicine is summarized in detail. With modifiable features, PBNPs can be used as drug carriers to improve the therapeutic efficacy. Moreover, the exchangeable protons and adsorbability enable PBNPs to decontaminate the radioactive ions from the body. For biomedical imaging, photoacoustic and magnetic resonance imaging based on PBNPs are summarized, as well as the strategies to improve the diagnostic effectiveness. The applications related to the photothermal effects and nanoenzyme activities of PBNPs are described. The challenges and critical factors for the clinical translation of PBNPs as multifunctional theranostic agents are also discussed. Finally, the future prospects for the application of PBNPs are considered. The aim of this review is to provide a better understanding and key consideration for rational design of this increasingly important new paradigm of PBNPs as theranostics.

Keywords: Prussian blue nanoparticles; clinical translations; drug delivery; imaging diagnostics; therapies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomedical Technology / methods*
  • Diagnostic Imaging
  • Drug Delivery Systems
  • Ferrocyanides / chemical synthesis
  • Ferrocyanides / chemistry*
  • Humans
  • Nanoparticles / chemistry*
  • Theranostic Nanomedicine

Substances

  • Ferrocyanides
  • ferric ferrocyanide